Detailed Narrative
Q2 Financials: Volumes Grow but Pricing Pressure Hits Margins
NOCIL's Q2 FY26 performance highlights a challenging market dynamic. The company achieved a 4% sequential growth in sales volumes, indicating resilient underlying demand. However, this was completely offset by intense pricing pressure, primarily from imports. Net revenue fell to ₹321 crores from ₹336 crores in Q1. Consequently, profitability took a significant hit, with Operating EBITDA declining to ₹22 crores at a 7% margin, compared to ₹31 crores in the previous quarter. Profit After Tax also fell sequentially to ₹12 crores from ₹17 crores.
Domestic Market and Anti-Dumping Measures
The domestic market, which constitutes two-thirds of the company's volumes, saw sequential growth. However, it remains the primary battleground for import dumping. Management estimates the domestic demand at 80,000-85,000 tons per annum, with NOCIL holding a 38-40% market share. To counter unfair competition, the company has filed anti-dumping petitions on key products (two antioxidants, two sulphonamides). The authorities have initiated an investigation, and management is reasonably confident💬 of a favorable finding within the next 2-3 months, which could be a key catalyst for margin recovery.
Export Headwinds from US Tariffs
The export business, representing one-third of volumes, faced a significant setback due to new US tariffs. This led to a decline in export volumes for the quarter and has created broader uncertainty in international markets. Management views this as a 'speed breaker' rather than a full stop and is in discussions with customers. However, they expect the export environment to remain 'choppy' for the next few months. Without the tariff impact🌐, the company's volume index would have been 140-142 instead of the reported 138, indicating a direct impact of 2-4 index points.
Dahej Expansion Project on Track
The company's major brownfield expansion for TDQ capacity at Dahej is progressing as planned. Management confirmed that 75-80% of the work is already completed. They are on track to commence trial production during the first half of the calendar year 2026 (H1 CY26). This project is a key part of NOCIL's long-term growth strategy and its timely execution is a positive signal amidst the current operational challenges.
Margin Pressure, Cost Initiatives, and Capacity Utilization
The core challenge for NOCIL is profitability, with the company operating at a low 65% capacity utilization. This prevents the absorption of fixed costs and hurts operating leverage. In response, management is implementing various cost optimization and operational efficiency initiatives focused on reducing consumption of steam, electricity, and hydrogen. They expect these measures to start yielding tangible benefits by the fourth quarter of the current financial year. Improved working capital efficiency was a bright spot, driven by better inventory management and lower raw material prices.